Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T63681 | DNA Gyrase-IN-1 | ||
DNA Gyrase-IN-1 是有效的、选择性的 DNA 促旋酶抑制剂 (IC50: 2.6 μM)。DNA Gyrase-IN-1 能够较好的抑制结核分枝杆菌 (Mtb) 的活性 (MIC: 0.49 μM)。DNA Gyrase-IN-1 能够用于研究结核病。 | |||
T62792 | 14α-Demethylase/DNA Gyrase-IN-1 | ||
14α-Demethylase/DNA Gyrase-IN-1 (Compound 7c) 是一种 14α-Demethylase/DNA Gyrase 的有效抑制剂,具有抗菌作用。 | |||
T64012 | DNA gyrase B-IN-1 | ||
DNA gyrase B-IN-1 是 DNA gyrase B 的有效抑制剂,表现出良好的结合亲和力和稳定性。DNA gyrase B-IN-1 能够抑制 P. aeruginosa/i> DNA gyrase B (IC50: 2.2 μM)。 | |||
T13231L |
Trovafloxacin mesylate
|
Others; DNA/RNA Synthesis; Topoisomerase; Antibacterial | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Others |
Trovafloxacin是一种广谱氟喹诺酮类抗生素,可阻断 DNA 促旋酶 (DNA gyrase) 和拓扑异构酶 IV (topoisomerase IV) 的活性,也是一种有效的特异性 pannexin 1 通道抑制剂 (PANX1, IC50 = 4 μM)。 | |||
T78776 | DNA gyrase B-IN-3 | DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
DNA gyrase B-IN-3(Compound A),作为一种细菌DNA gyrase B抑制剂(IC50: <10 nM),针对革兰氏阳性菌株表现出抗菌活性。 | |||
T78712 |
DNA Gyrase-IN-8
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
DNA Gyrase-IN-8是一种高效的DNA gyrase抑制剂,其IC50为8.45 µM,同时展现出了抗菌活性。 | |||
T78866 |
DNA Gyrase-IN-9
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
DNA Gyrase-IN-9 (compound 4j) 是一款抗细菌剂,作用于 DNA gyrase。该化合物对抑制革兰氏阳性菌的最小抑菌浓度(MIC)范围为 0.5-2 μg/mL,最小杀菌浓度(MBC)为 2-8 μg/mL。在金黄色葡萄球菌中,DNA Gyrase-IN-9 的 DNA gyrase 抑制半数有效浓度(IC50)为 6.29 μg/mL。 | |||
T36106 |
Coumermycin A1
|
||
Coumermycin A1 is a JAK2 signal activator. Coumermycin A1 inhibits DNA Gyrase which thereby inhibits cell division in bacteria. Coumermycin A1-induced-JAK2 signal activation increases the mRNA level of SCOS2, but reducea leptin receptor mRNA level[1]. [1]. Tiantian Zhang, et al. SOCS2 Inhibits Mitochondrial Fatty Acid Oxidation via Suppressing LepR/JAK2/AMPK Signaling Pathway in Mouse Adipocytes. Research Article. | |||
T79240 |
DNA gyrase B-IN-2
|
||
DNA gyrase B-IN-2 (Compound E) 是一款基于2-aminobenzothiazole的DNA gyrase B抑制剂,针对ESKAPE病原体显示出强效活性。该化合物在低纳摩尔浓度下表现出优异的DNA gyrase B抑制能力(IC50< 10 nM),具备对多种ESKAPE病原体的广谱抗菌作用。对于大部分革兰氏阳性菌,最低抑菌浓度(MIC)低于0.03 μg/mL;针对革兰氏阴性病原体如E. coli, Acinetobacter baumannii, Pseudomonas aeruginosa和Klebsiella pneumoniae,MIC为4 - 16 μg/mL。此化合物适用于感染性疾病的研究应用。 | |||
T61054 | Type II topoisomerase inhibitor 1 | ||
Type II topoisomerase inhibitor 1 可用于抗菌领域。Type II topoisomerase inhibitor 1 是大肠杆菌DNA 旋转酶的选择性抑制剂,IC50值为 1.7 nM,并能与 Asp73 残基形成氢键。Type II topoisomerase inhibitor 1 抑制拓扑异构酶 IV 的活性,IC50值为 0.98 μM。 | |||
T36021 |
Flumequine-13C3
Flumequine-13C3 |
||
Flumequine-13C3is intended for use as an internal standard for the quantification of flumequine by GC- or LC-MS. Flumequine is a fluoroquinolone antibiotic.1It is active againstS. aureus, S. pyogenes, B. subtilis, E. coli, P. aeruginosa, S. faecalis, andK. pneumoniae(MICs = 1-100 μg/ml). Flumequine is also active against field isolates of B. hyodysenteriae (MICs = 6.25-200 μg/ml).2It inhibits DNA gyrase, disrupting supercoiling of bacterial DNA to block transcription and replication.3In vivo, fl... |